Abstract
Cardiovascular disease is the result of complicated pathophysiological processes in the tissues that make up the blood vessels and heart. Heat shock protein 90 (HSP90) can interact with 10% of the proteome and is the most widely studied molecular chaperone in recent years. HSP90 is extensively involved in the regulation of protein folding and intracellular protein stability, making HSP90 a hopeful target for the treatment of multiple cardiovascular diseases. Numerous client proteins of HSP90 have been identified in known cardiac disease pathways, including MAPK signaling, PI3K/AKT (PKB)/mTOR, and TNF-α signaling. Therefore, these pathways can be controlled by regulating HSP90. Among them, the activity of HSP90 can be regulated via numerous inhibitors. In this review, first, we will discuss the function of HSP90 and its role in pathological pathways. In addition, HSP90 plays a significant role in most cardiovascular diseases, including hypertension, pulmonary venous hypertension, atherosclerosis, and heart failure; next we will focus on this part. Finally, we will summarize the currently known HSP90 inhibitors and their potential in the treatment of heart disease.
Funder
Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences
Reference187 articles.
1. New Puffing Pattern Induced by Temperature Shock and Dnp in Drosophila;Ritossa;Experientia,1962
2. Hoter, A., El-Sabban, M.E., and Naim, H.Y. The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease. Int. J. Mol. Sci., 2018. 19.
3. The heat-shock response;Lindquist;Annu. Rev. Biochem.,1986
4. Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers;Richardson;Br. J. Haematol.,2011
5. Heat shock proteins in vascular disease—A review;Mehta;Eur. J. Vasc. Endovasc. Surg.,2005